Download fulltext
HTML
1.
Rad-Malekshahi M. Editorial – Polymeric Nanoparticles for Retinal Drug Delivery. JOVR [Internet]. 2024Mar.10 [cited 2024Apr.27];19(1):4–5. Available from: https://knepublishing.com/index.php/JOVR/article/view/15417
https://doi.org/10.18502/jovr.v19i1.15417
statistics
- 139 Abstract Views
- 134 PDF Views
- 0 HTML Views
authors
-
Mazda Rad-Malekshahi
Mazda Rad-Malekshahi
Department of Pharmaceutical Biomaterials and Medical Biomaterials Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
Published Date
- Mar 10, 2024
Editorial – Polymeric Nanoparticles for Retinal Drug Delivery
Abstract
This is an Editorial and does not have an abstract. Please download the PDF or view the article in HTML.
Keywords:
N/A
References
1. Akhter MH, Ahmad I, Alshahrani MY, Al-Harbi AI, Khalilullah H, Afzal O, et al. Drug delivery challenges and current progress in nanocarrier-based ocular therapeutic system. Gels 2022;8:82.
2. Hennig R, Goepferich A. Nanoparticles for the treatment of ocular neovascularizations. Eur J Pharm Biopharm 2015;95:294–306.
3. Formica ML, Awde Alfonso HG, Palma SD. Biological drug therapy for ocular angiogenesis: Anti-VEGF agents and novel strategies based on nanotechnology. Pharmacol Res Perspect 2021;9:e00723.
4. Del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems: A shift to the posterior segment. Drug Discov Today 2008;13:135–143.
5. Shen H-H, Chan EC, Lee JH, Bee Y-S, Lin T-W, Dusting GJ, et al. Nanocarriers for treatment of ocular neovascularization in the back of the eye: New vehicles for ophthalmic drug delivery. Nanomedicine 2015;10:2093– 2107.
6. Chaharband F, Varshochian R, Dinarvand R, Sabbaghi H, Kanavi MR, Daftarian N, Nourinia R. Polymeric Propranolol Nanoparticles for Intraocular Delivery: Formulation, Characterization, and Vitreous Pharmacokinetics. J Ophthalmic Vis Res 2024;19:41–51.
7. Nourinia R, Rezaei Kanavi M, Kaharkaboudi A, Taghavi SI, Aldavood SJ, Darjatmoko SR, et al. Ocular safety of intravitreal propranolol and its efficacy in attenuation of choroidal neovascularization. Invest Ophthalmol Vis Sci 2015;56:8228–8235.
8. Karimi S, Nikkhah H, Ahmadieh H, Safi S. Intravitreal injection of propranolol for the treatment of retinal capillary hemangioma in a case of von hippel-lindau. Retin Cases Brief Rep 2020;14:305–309.
9. Varshochian R, Riazi-Esfahani M, Jeddi-Tehrani M, Mahmoudi AR, Aghazadeh S, Mahbod M, et al. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res A 2015;103:3148–3156.
10. Chaharband F, Daftarian N, Kanavi MR, Varshochian R, Hajiramezanali M, Norouzi P, et al. Trimethyl chitosanhyaluronic acid nano-polyplexes for intravitreal VEGFR- 2 siRNA delivery: Formulation and in vivo efficacy evaluation. Nanomedicine 2020;26:102181.
2. Hennig R, Goepferich A. Nanoparticles for the treatment of ocular neovascularizations. Eur J Pharm Biopharm 2015;95:294–306.
3. Formica ML, Awde Alfonso HG, Palma SD. Biological drug therapy for ocular angiogenesis: Anti-VEGF agents and novel strategies based on nanotechnology. Pharmacol Res Perspect 2021;9:e00723.
4. Del Amo EM, Urtti A. Current and future ophthalmic drug delivery systems: A shift to the posterior segment. Drug Discov Today 2008;13:135–143.
5. Shen H-H, Chan EC, Lee JH, Bee Y-S, Lin T-W, Dusting GJ, et al. Nanocarriers for treatment of ocular neovascularization in the back of the eye: New vehicles for ophthalmic drug delivery. Nanomedicine 2015;10:2093– 2107.
6. Chaharband F, Varshochian R, Dinarvand R, Sabbaghi H, Kanavi MR, Daftarian N, Nourinia R. Polymeric Propranolol Nanoparticles for Intraocular Delivery: Formulation, Characterization, and Vitreous Pharmacokinetics. J Ophthalmic Vis Res 2024;19:41–51.
7. Nourinia R, Rezaei Kanavi M, Kaharkaboudi A, Taghavi SI, Aldavood SJ, Darjatmoko SR, et al. Ocular safety of intravitreal propranolol and its efficacy in attenuation of choroidal neovascularization. Invest Ophthalmol Vis Sci 2015;56:8228–8235.
8. Karimi S, Nikkhah H, Ahmadieh H, Safi S. Intravitreal injection of propranolol for the treatment of retinal capillary hemangioma in a case of von hippel-lindau. Retin Cases Brief Rep 2020;14:305–309.
9. Varshochian R, Riazi-Esfahani M, Jeddi-Tehrani M, Mahmoudi AR, Aghazadeh S, Mahbod M, et al. Albuminated PLGA nanoparticles containing bevacizumab intended for ocular neovascularization treatment. J Biomed Mater Res A 2015;103:3148–3156.
10. Chaharband F, Daftarian N, Kanavi MR, Varshochian R, Hajiramezanali M, Norouzi P, et al. Trimethyl chitosanhyaluronic acid nano-polyplexes for intravitreal VEGFR- 2 siRNA delivery: Formulation and in vivo efficacy evaluation. Nanomedicine 2020;26:102181.